Duori Pharmaceuticals: Stock trading resumes starting February 27th

NightAirdropper · 2026-02-27T15:46:00+00:00

Dory Pharmaceuticals announces that its stock will resume trading on February 27, 2026. The company has implemented a partial tender offer, acquiring a total of 19.44 million shares, accounting for 24.30% of the total share capital. After the acquisition, the acquirer and its concerted parties hold a total of 53.90% of the company's shares, and the shareholding distribution meets the listing requirements.

NightAirdropper

2026-02-27 15:46:00

Abstract generation in progress

Everyday AI Express, February 26 — DuRui Pharmaceutical announced that its stock will resume trading starting from the market opening on February 27, 2026 (Friday). The company conducted partial tender offers from January 22 to February 24, 2026, led by Wang Qingtai and Cao Xiaobing to all shareholders except their concerted parties. The targeted number of shares to be acquired is 19.44 million, accounting for 24.30% of the company’s total share capital, with a tender offer price of 32.07 yuan per share. As of February 24, when the tender offer period ended, Wang Qingtai accepted 17.6006 million shares, and Cao Xiaobing accepted 1.8514 million shares; based on proportional acquisition rules, the total shares acquired by the bidders amount to 19.44 million. After this tender offer is completed, the bidders and their concerted parties will hold a total of 43.12 million shares, representing 53.90% of the company’s total share capital. The company’s equity distribution remains compliant with listing requirements, and its listing status is unaffected.

Daily Economic News

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.